Clofarabine
Product manufactured by Winthrop U.s.
Indications and Purposes
| 1 Indications And Usage Clofarabine Is Indicated For The Treatment Of Pediatric Patients 1 To 21 Years Old With Relapsed Or Refractory Acute Lymphoblastic Leukemia After At Least Two Prior Regimens. This Indication Is Based Upon Response Rate. There Are No Trials Verifying An Improvement In Disease-Related Symptoms Or Increased Survival With Clofarabine. Clofarabine Is A Nucleoside Metabolic Inhibitor Indicated For The Treatment Of Pediatric Patients 1 To 21 Years Old With Relapsed Or Refractory Acute Lymphoblastic Leukemia After At Least Two Prior Regimens. This Indication Is Based Upon Response Rate. There Are No Trials Verifying An Improvement In Disease-Related Symptoms Or Increased Survival With Clofarabine. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Clofarabine |
|
ZINC3798247 |